Biocept Stock Analysis

Biocept Stock Analysis Notes

The company has price-to-book (P/B) ratio of 0.29. Some equities with similar Price to Book (P/B) outperform the market in the long run. Biocept recorded a loss per share of 48.17. The entity last dividend was issued on the 8th of September 2020. The firm had 1:30 split on the 17th of May 2023. For more info on Biocept please contact the company at 858 320 8200 or go to https://biocept.com.

Biocept Investment Alerts

Biocept Largest EPS Surprises

View All Earnings Estimates

Biocept Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 262.

Biocept Profitablity

Management Efficiency

Biocept has return on total asset (ROA) of (0.5165) % which means that it has lost $0.5165 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.8694) %, meaning that it generated substantial loss on money invested by shareholders. Biocept's management efficiency ratios could be used to measure how well Biocept manages its routine affairs as well as how well it operates its assets and liabilities. As of 01/20/2026, Return On Tangible Assets is likely to drop to -0.98. In addition to that, Return On Capital Employed is likely to drop to -1.52. At this time, Biocept's Total Current Liabilities is relatively stable compared to the past year. As of 01/20/2026, Liabilities And Stockholders Equity is likely to grow to about 43 M, while Non Current Liabilities Total is likely to drop slightly above 11 M.

Technical Drivers

As of the 20th of January, Biocept shows the Standard Deviation of 234.66, risk adjusted performance of 0.093, and Mean Deviation of 58.9. Biocept technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Biocept Price Movement Analysis

Biocept Outstanding Bonds

Biocept Predictive Daily Indicators

Biocept Forecast Models

Biocept's time-series forecasting models are one of many Biocept's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Biocept's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Biocept Bond Ratings

Biocept financial ratings play a critical role in determining how much Biocept have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Biocept's borrowing costs.

Biocept Total Assets Over Time

Biocept Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Biocept uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Biocept Debt Ratio

43.0

It seems slightly above 57% of Biocept's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Biocept's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Biocept, which in turn will lower the firm's financial flexibility.

Biocept Corporate Bonds Issued

Biocept Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Biocept prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Biocept shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Biocept. By using and applying Biocept Stock analysis, traders can create a robust methodology for identifying Biocept entry and exit points for their positions.

When running Biocept's price analysis, check to measure Biocept's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biocept is operating at the current time. Most of Biocept's value examination focuses on studying past and present price action to predict the probability of Biocept's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biocept's price. Additionally, you may evaluate how the addition of Biocept to your portfolios can decrease your overall portfolio volatility.